Buprenorphine And Naloxone 00228-3154
Product NDC
00228-3154- Manufacturer
- Actavis Pharma, Inc.
- Dosage Form
- Tablet
- Route
- Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- March 4, 2013
- Listing Expires
- December 31, 2027
- Application
- ANDA091422
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 2 mg/1 |
| Naloxone Hydrochloride Dihydrate | .5 mg/1 |
Drug Class
Opioid Antagonist [EPC]Opioid Antagonists [MoA]Partial Opioid Agonist [EPC]
Packaging Options(1)
30 TABLET in 1 BOTTLE (0228-3154-03)